Antonin Levy

Antonin Levy

Molecular Microbial Pathogenesis Unit, Institut Pasteur

Affiliated withInstitut PasteurUniversité Paris-Saclay

Research Area

Biography

Antonin Levy has not added Biography.
If you are Antonin Levy and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Analyzing Oxidative Stress in Murine Intestinal Organoids using Reactive Oxygen Species-Sensitive Fluorogenic Probe
Publication title

Cited by 1

2021

Other Publications

Article
Year
Concurrent irradiation with the anti-programmed cell death ligand-1 immune checkpoint blocker durvalumab: Single centre subset analysis from a phase 1/2 trial.

European journal of cancer (Oxford, England : 1990)| PubMed ID: 27764686

2016
2016
Candidate immune biomarkers for radioimmunotherapy.

Biochimica et biophysica acta| PubMed ID: 28254528

2017
The Current Role of Whole Brain Radiation Therapy in Non-Small Cell Lung Cancer Patients.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer| PubMed ID: 28733269

2017
Concerns about cardiotoxicity in the HERA trial.

Lancet (London, England)| PubMed ID: 29303721

2017
2018
Metformin for non-small cell lung cancer patients: Opportunities and pitfalls.

Critical reviews in oncology/hematology| PubMed ID: 29650275

2018
Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer Patients: Secondary Findings From the Prospective Randomized Phase 3 CONVERT Trial.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer| PubMed ID: 30292850

2019
Plerixafor for the Treatment of WHIM Syndrome.

The New England journal of medicine| PubMed ID: 30995387

2019
[Therapeutic options for oligoprogressive non-small cell lung cancer].

Revue des maladies respiratoires| PubMed ID: 31010758

2019
2019
Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinion.

European journal of cancer (Oxford, England : 1990)| PubMed ID: 31655358

2019
EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease.

European journal of cancer (Oxford, England : 1990)| PubMed ID: 31671363

2019
Innate immune receptor NOD2 mediates LGR5 intestinal stem cell protection against ROS cytotoxicity via mitophagy stimulation.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 31919280

2020
[Role of immunotherapy in locally advanced non-small cell lung cancer].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique| PubMed ID: 32037126

2020
Methodological Development of Combination Drug and Radiotherapy in Basic and Clinical Research.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 32409306

2020
Palliation of dysphagia in metastatic oesogastric cancers: An international multidisciplinary position.

European journal of cancer (Oxford, England : 1990)| PubMed ID: 32563014

2020
[Radiation-oncology horizon 2030: From microbiota to plasma laser].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique| PubMed ID: 32861611

2020
Can radiation-recall predict long lasting response to immune checkpoint inhibitors?

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology| PubMed ID: 32976876

2021
Drug-Radiotherapy Combination Trial Developments-Response.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 33397680

2021
[Radiotherapy for oligometastatic non-small cell lung cancer patients].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique| PubMed ID: 34175225

2021
2021